Want to see VTR full AI Analyst Report?
Top Page
Ventas
(NYSE:VTR)
Select Model
Select Model
Rating:66Neutral
Price Target:
$99.00
â–¼(-1.52% Downside)
Action:Reiterated
Date:07/31/26
The score is primarily supported by strong and improving cash flow generation and a positive earnings-call setup featuring raised FFO guidance, accelerating SHOP fundamentals (NOI, occupancy, margins), and improved leverage metrics. The main offsets are valuation risk from an extremely high P/E and moderate balance-sheet/earnings-quality concerns, while technicals are mixed with near-term softness but a still-positive longer-term trend.
Positive Factors
Strong Cash Generation
Ventas’s rising operating and free cash flow provides durable internal funding for dividends, reinvestment, and opportunistic acquisitions. Over 2–6 months this reduces dependence on volatile capital markets, supports the ATM program use, and underpins the firm’s ability to execute accretive SHOP investments.
Negative Factors
Elevated Leverage
Despite recent improvement, multi-year leverage remains meaningful for a defensive REIT. Elevated debt ratios limit flexibility if rates rise or SHOP cash flows soften, and a TTM data inconsistency lowers confidence in the precise leverage picture when planning funding or large deployments.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Cash Generation
Ventas’s rising operating and free cash flow provides durable internal funding for dividends, reinvestment, and opportunistic acquisitions. Over 2–6 months this reduces dependence on volatile capital markets, supports the ATM program use, and underpins the firm’s ability to execute accretive SHOP investments.
Read all positive factors
Ventas Key Performance Indicators (KPIs)
Any
Revenue by Type
Separates revenue into categories like contractual rent, operating income from managed communities, and fees, clarifying which cash flows are recurring versus variable. For investors in Ventas, this helps judge dividend sustainability and the sensitivity of revenue to occupancy, reimbursement, or management performance.
Separates revenue into categories like contractual rent, operating income from managed communities, and fees, clarifying which cash flows are recurring versus variable. For investors in Ventas, this helps judge dividend sustainability and the sensitivity of revenue to occupancy, reimbursement, or management performance.
Data provided by:
The Fly
The FlyVentas (VTR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$45.60B
Dividend Yield2.25%
Average Volume (3M)3.61M
Price to Earnings (P/E)161.9
Beta (1Y)0.18
Revenue Growth21.49%
EPS Growth26.45%
CountryUS
Employees542
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)0.55
Shares Outstanding512,946,350
10 Day Avg. Volume2,742,027
30 Day Avg. Volume3,605,645
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)2.81
Price to Sales (P/S)6.04
P/FCF Ratio26.75
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$99.54Price Target Upside-0.99% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)0.62
Revenue Forecast (FY)$6.89B
Ventas Business Overview & Revenue Model
Company Description
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property v...
How the Company Makes Money
Ventas primarily makes money by owning healthcare-related real estate and earning cash flows from it in several ways. (1) Rental and lease income: For properties leased to third-party operators (e.g., many medical office, outpatient, and similar a...
Ventas Earnings Call Summary
Earnings Call Date:Jul 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call emphasized strong operating momentum driven by senior housing: robust same‑store NOI (10% total, 16% SHOP), occupancy gains (300 bps+), revenue and margin expansion, and an upgraded investment plan to $4.5B for 2026. Balance sheet metrics improved (net debt/EBITDA 4.7x, $4.9B liquidity) and FFO guidance was raised. Challenges noted include interest rate/FX headwinds, development economics that currently do not pencil, competitive market pricing, and some non‑core asset recycling. On balance, positive operational execution, upgraded guidance, and an active accretive investment program materially outweigh the listed challenges.Positive Updates
Strong Same‑Store NOI Growth
Total company same‑store cash NOI increased 10% year‑over‑year; same‑store SHOP NOI rose 16% Y/Y with U.S. SHOP leading at 18% Y/Y.
Negative Updates
Interest Rate and FX Headwinds
Higher interest rates and a stronger U.S. dollar (and stronger share price) reduced the FFO guide by roughly $0.01 per share and were cited as partial offsets to investment benefits.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Same‑Store NOI Growth
Total company same‑store cash NOI increased 10% year‑over‑year; same‑store SHOP NOI rose 16% Y/Y with U.S. SHOP leading at 18% Y/Y.
Read all positive updates
Company Guidance
Ventas raised and refined its 2026 outlook: normalized FFO is now $3.85–$3.90/share (midpoint $3.88, +8–10% YoY; Q2 normalized FFO $0.97, +9% YoY) and full‑year net income is guided to $0.58–$0.63/share (midpoint $0.61). Management reaffirmed SHOP same‑store NOI guidance of ~16% (total company same‑store NOI was +10% in Q2), raised full‑year same‑store occupancy growth to ~300 bps YoY (Q2 U.S. SHOP: +18% NOI, +360 bps occupancy), and reported RevPOR +5%, same‑store revenue ≈+9%, same‑store operating expenses ≈+5%, NOI margin up 210 bps to 31% and incremental margin flow‑through ≈55%. Capital deployment assumptions were increased to $4.5B of 2026 senior‑housing investments (from $3B) with YTD investments >$3B (≈$3.4B), average expected year‑1 yield ~6.6% and double‑digit to mid‑teens unlevered IRRs, dispositions/loan repayments raised to ~$700M, liquidity ≈$4.9B and net debt/EBITDA improved to ~4.7x.Ventas Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
58
Neutral
Cash Flow
76
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.44B | 5.83B | 4.92B | 4.50B | 4.13B | 3.83B |
| Gross Profit | -166.48M | -344.22M | 2.10B | 1.94B | 1.85B | 1.74B |
| EBITDA | 2.50B | 2.24B | 1.94B | 1.95B | 1.62B | 1.72B |
| Net Income | 266.27M | 251.38M | 81.15M | -40.97M | -47.45M | 49.01M |
Balance Sheet | ||||||
| Total Assets | 29.66B | 27.59B | 26.19B | 24.73B | 24.16B | 24.72B |
| Cash, Cash Equivalents and Short-Term Investments | 198.96M | 741.07M | 897.85M | 508.79M | 122.56M | 149.72M |
| Total Debt | 13.65B | 13.22B | 13.74B | 13.69B | 12.49B | 12.22B |
| Total Liabilities | 14.44B | 15.01B | 15.36B | 15.18B | 13.94B | 13.77B |
| Stockholders Equity | 14.65B | 12.53B | 10.77B | 9.49B | 10.15B | 10.85B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 1.32B | 1.06B | 935.13M | 926.34M | 858.69M |
| Operating Cash Flow | 1.84B | 1.68B | 1.34B | 1.19B | 1.15B | 1.04B |
| Investing Cash Flow | -4.66B | -2.73B | -2.39B | -239.20M | -882.33M | -764.48M |
| Financing Cash Flow | 2.38B | 875.73M | 1.45B | -563.88M | -289.13M | -535.97M |
Ventas Technical Analysis
Neutral
100.53
Price Trends
89.53
Negative
87.14
Positive
82.90
Positive
Market Momentum
-0.37
Positive
42.49
Neutral
21.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VTR, the sentiment is Neutral. The current price of 100.53 is above the 20-day moving average (MA) of 94.49, above the 50-day MA of 89.53, and above the 200-day MA of 82.90, indicating a neutral trend. The MACD of -0.37 indicates Positive momentum. The RSI at 42.49 is Neutral, neither overbought nor oversold. The STOCH value of 21.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VTR.
Ventas Risk Analysis
Ventas disclosed 52 risk factors in its most recent earnings report. Ventas reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ventas Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $162.90B | 119.33 | 3.15% | 1.17% | 37.49% | -142.31% | |
74 Outperform | $13.81B | 15.87 | 16.51% | 5.18% | 15.18% | 72.69% | |
66 Neutral | $45.60B | 161.85 | 2.02% | 1.99% | 21.49% | 26.45% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $5.07B | 76.48 | 2.34% | 5.37% | 18.43% | -65.50% | |
63 Neutral | $6.56B | -73.24 | -1.94% | 4.49% | -6.28% | 77.63% | |
62 Neutral | $14.49B | 59.03 | 3.30% | 5.48% | 5.52% | 48.98% |
* Real Estate Sector Average
VTR
Ventas
89.01
22.70
34.23%
DOC
Healthpeak Properties
20.66
4.64
28.96%
WELL
Welltower
230.27
69.60
43.32%
OHI
Omega Healthcare
45.87
7.78
20.43%
SBRA
Sabra Healthcare REIT
20.19
2.77
15.91%
HR
Healthcare Realty Trust
19.21
3.59
23.00%
Ventas Corporate Events
Executive/Board Changes
Ventas Announces General Counsel Transition and Interim Successor
Neutral
Jun 15, 2026
On June 15, 2026, Ventas, Inc. announced that Executive Vice President, General Counsel, Ethics Compliance Officer and Corporate Secretary Carey S. Roberts has notified the company of her intention to resign effective June 26, 2026, to become Sen...
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and FinancingShareholder Meetings
Ventas Expands ATM Program to Bolster Capital Flexibility
Positive
May 15, 2026
On May 12, 2026, Ventas finalized a separation and release agreement with retiring executive Peter J. Bulgarelli, under which he will receive a prorated 2026 bonus in exchange for a release of claims and adherence to restrictive covenants, marking...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.